We found that peptides containing the heparin-binding domain derived from the C-terminus of IGFBP-5 inhibited angiogenesis and tumor growth by regulation of the Akt/ERK and NF-kB–VEGF/MMP-9 signaling pathway in an IGF-independent manner. The gene discussed is AKT1; the disease is neoplasm.